Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses.
Roshell MuirTalibah MetcalfSlim FouratiYannic BartschJacqueline Kyosiimire LugemwaGlenda CanderanGalit AlterEnoch MuyanjaBrenda OkechTeddy NamatovuIrene NamaraAnnemarie NamuniinaAli SsetaalaJuliet MpendoAnnet NanvubyaPaul Kato KitandweBernard S BagayaNoah KiwanukaJacent NassunaVictoria Menya BiribawaAlison M ElliottClaudia J de DoodWilliam SenyongaPriscilla BalungiPontiano KaleebuYunia MayanjaMathew OdongoPat FastMatt A PricePaul L A M CorstjensGovert J van DamAnatoli KamaliRafick Pierre SekalyElias K HaddadPublished in: medRxiv : the preprint server for health sciences (2023)
) infection on Hepatitis B (HepB) vaccination of individuals from a fishing community in Uganda. We demonstrate that high schistosome-specific antigen (circulating anodic antigen, CAA) concentration pre-vaccination, is associated with lower HepB antibody titers post-vaccination. We show higher pre-vaccination levels of cellular and soluble factors in instances of high CAA that are negatively associated with HepB antibody titers post-vaccination, which coincided with lower frequencies of circulating T follicular helper cell populations (cTfh), proliferating antibody secreting cells (ASCs), and higher frequencies of regulatory T cells (Tregs). We also show that monocyte function is important in HepB vaccine responses, and that high CAA is associated with alterations in the early innate cytokine/chemokine microenvironment. Our findings suggest that in individuals with high CAA and likely high worm burden, schistosomiasis creates and sustains an environment that is polarized against optimal host immune responses to the vaccine, which puts many endemic communities at risk for infection against HepB and other diseases that are preventable by vaccines.